Literature DB >> 2995437

Competitive enzyme immunoassays for the rapid detection of antibodies to feline infectious peritonitis virus polypeptides.

S A Fiscus, Y A Teramoto, M M Mildbrand, C V Knisley, S E Winston, N C Pedersen.   

Abstract

Monoclonal antibodies specific for the envelope (E1), peplomer (E2), and nucleocapsid (N) polypeptides of feline infectious peritonitis virus (FIPV) were used in rapid, competitive enzyme-linked immunosorbent assays (ELISA) to study the humoral immune response of cats to FIPV infection. Results from the competitive ELISAs were correlated with those from immunofluorescent antibody assays (IFAs) on 203 samples obtained from 64 individual cats. The IFA results correlated best with those obtained with the anti-E1 specific competitive ELISA (85.7%). In contrast, anti-N and anti-E2 competitive ELISA results correlated with IFA results only 65.5 and 2.4% of the time, respectively. The results of the anti-E1 specific competitive ELISA were not influenced by the total immunoglobulin concentration or the possible presence of free viral antigens in the serum. These results suggest that a competitive ELISA involving the use of enzyme-conjugated monoclonal antibody to the E1 glycoprotein of FIPV is a simple and rapid replacement for the more cumbersome IFA.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2995437      PMCID: PMC268418          DOI: 10.1128/jcm.22.3.395-401.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  FIP antibody test--interpretation and recommendations.

Authors:  F W Scott
Journal:  J Am Vet Med Assoc       Date:  1979-12-01       Impact factor: 1.936

2.  Antibody to virus components in volunteers experimentally infected with human coronavirus 229E group viruses.

Authors:  M R Macnaughton; H J Hasony; M H Madge; S E Reed
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

3.  Immunologic phenomena in the effusive form of feline infectious peritonitis.

Authors:  N C Petersen; J F Boyle
Journal:  Am J Vet Res       Date:  1980-06       Impact factor: 1.156

4.  SDS microslab linear gradient polyacrylamide gel electrophoresis.

Authors:  P T Matsudaira; D R Burgess
Journal:  Anal Biochem       Date:  1978-07-01       Impact factor: 3.365

5.  Feline infectious peritonitis: a worldwide serosurvey.

Authors:  M C Horzinek; A D Osterhaus
Journal:  Am J Vet Res       Date:  1979-10       Impact factor: 1.156

6.  Pathogenicity studies of feline coronavirus isolates 79-1146 and 79-1683.

Authors:  N C Pedersen; J F Evermann; A J McKeirnan; R L Ott
Journal:  Am J Vet Res       Date:  1984-12       Impact factor: 1.156

7.  Isolation and characterization of feline C3 and evidence for the immune complex pathogenesis of feline infectious peritonitis.

Authors:  H E Jacobse-Geels; M R Daha; M C Horzinek
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

8.  Infection studies in kittens, using feline infectious peritonitis virus propagated in cell culture.

Authors:  N C Pedersen; J F Boyle; K Floyd
Journal:  Am J Vet Res       Date:  1981-03       Impact factor: 1.156

9.  An enteric coronavirus infection of cats and its relationship to feline infectious peritonitis.

Authors:  N C Pedersen; J F Boyle; K Floyd; A Fudge; J Barker
Journal:  Am J Vet Res       Date:  1981-03       Impact factor: 1.156

10.  The virology and pathogenesis of feline infectious peritonitis. Brief review.

Authors:  M C Horzinek; A D Osterhaus
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

View more
  10 in total

1.  Rapid detection of viral-specific antibodies by enzyme-linked immunosorbent assay (ELISA).

Authors:  S Winston; S Fiscus; L Hesterberg; T Matsushita; M Mildbrand; J Porter; Y Teramoto
Journal:  Vet Immunol Immunopathol       Date:  1987-12       Impact factor: 2.046

2.  Peptidoglycan-associated polypeptides of Mycobacterium tuberculosis.

Authors:  G R Hirschfield; M McNeil; P J Brennan
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

3.  Epitope-specific antibody responses to virulent and avirulent feline infectious peritonitis virus isolates.

Authors:  S A Fiscus; B L Rivoire; Y A Teramoto
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

4.  Prevalence and implications of feline coronavirus infections of captive and free-ranging cheetahs (Acinonyx jubatus).

Authors:  J L Heeney; J F Evermann; A J McKeirnan; L Marker-Kraus; M E Roelke; M Bush; D E Wildt; D G Meltzer; L Colly; J Lukas
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

5.  Antigenic comparison of feline coronavirus isolates: evidence for markedly different peplomer glycoproteins.

Authors:  S A Fiscus; Y A Teramoto
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

6.  Antigenic analysis of feline coronaviruses with monoclonal antibodies (MAbs): preparation of MAbs which discriminate between FIPV strain 79-1146 and FECV strain 79-1683.

Authors:  T Hohdatsu; T Sasamoto; S Okada; H Koyama
Journal:  Vet Microbiol       Date:  1991-06       Impact factor: 3.293

7.  Comparative features of a coronavirus isolated from a cheetah with feline infectious peritonitis.

Authors:  J F Evermann; J L Heeney; A J McKeirnan; S J O'Brien
Journal:  Virus Res       Date:  1989-05       Impact factor: 3.303

8.  Biological and pathological consequences of feline infectious peritonitis virus infection in the cheetah.

Authors:  J F Evermann; J L Heeney; M E Roelke; A J McKeirnan; S J O'Brien
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

Review 9.  Perspectives on the epizootiology of feline enteric coronavirus and the pathogenesis of feline infectious peritonitis.

Authors:  J F Evermann; A J McKeirnan; R L Ott
Journal:  Vet Microbiol       Date:  1991-08-15       Impact factor: 3.293

10.  An enzyme-linked immunosorbent assay using canine coronavirus-infected CRFK cells as antigen for detection of anti-coronavirus antibody in cat.

Authors:  M Mochizuki; H Furukawa
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1989       Impact factor: 2.268

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.